Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Sep 19:7:359.
doi: 10.3389/fimmu.2016.00359. eCollection 2016.

Dexamethasone and Monophosphoryl Lipid A-Modulated Dendritic Cells Promote Antigen-Specific Tolerogenic Properties on Naive and Memory CD4+ T Cells

Affiliations

Dexamethasone and Monophosphoryl Lipid A-Modulated Dendritic Cells Promote Antigen-Specific Tolerogenic Properties on Naive and Memory CD4+ T Cells

Jaxaira Maggi et al. Front Immunol. .

Abstract

Tolerogenic dendritic cells (DCs) are a promising tool to control T cell-mediated autoimmunity. Here, we evaluate the ability of dexamethasone-modulated and monophosphoryl lipid A (MPLA)-activated DCs [MPLA-tolerogenic DCs (tDCs)] to exert immunomodulatory effects on naive and memory CD4+ T cells in an antigen-specific manner. For this purpose, MPLA-tDCs were loaded with purified protein derivative (PPD) as antigen and co-cultured with autologous naive or memory CD4+ T cells. Lymphocytes were re-challenged with autologous PPD-pulsed mature DCs (mDCs), evaluating proliferation and cytokine production by flow cytometry. On primed-naive CD4+ T cells, the expression of regulatory T cell markers was evaluated and their suppressive ability was assessed in autologous co-cultures with CD4+ effector T cells and PPD-pulsed mDCs. We detected that memory CD4+ T cells primed by MPLA-tDCs presented reduced proliferation and proinflammatory cytokine expression in response to PPD and were refractory to subsequent stimulation. Naive CD4+ T cells were instructed by MPLA-tDCs to be hyporesponsive to antigen-specific restimulation and to suppress the induction of T helper cell type 1 and 17 responses. In conclusion, MPLA-tDCs are able to modulate antigen-specific responses of both naive and memory CD4+ T cells and might be a promising strategy to "turn off" self-reactive CD4+ effector T cells in autoimmunity.

Keywords: hyporesponsiveness; immunotherapy; memory CD4+ T cells; monocyte-derived dendritic cells; naive CD4+ T cells; tolerance.

PubMed Disclaimer

Figures

Figure 1
Figure 1
MPLA-tDCs are characterized by low expression of maturation markers, diminished endocytosis ability, and the capability to present antigen efficiently. For the induction of a tolerogenic state, DCs were conditioned with dexamethasone (Dex) and were additionally activated with MPLA (MPLA-tDCs). Untreated DCs (iDCs), Dex-modulated DCs (tDCs), and MPLA-matured DCs (mDCs) were used as controls. (A) Representative dot plots of cell viability measured after 5 days of culture and expressed as the percentage of annexin-V and 7-AAD-negative cells are shown, and DC yield is expressed as a percentage of DCs obtained on day 5 related to the initial number of monocytes cultured per condition (mean ± SEM) (n = 10). (B) Surface expression levels of CD86, CD80, CD83, and HLA-DR were assessed by flow cytometry. Graphic analyses of MFI measurements are expressed as box-and-whiskers plot from minimum to maximum values (n = 6). Statistical differences were calculated using one-way ANOVA for repeated measures followed by Tukey post-test (*P < 0.05; **P < 0.01; ***P < 0.001). (C) Endocytosis capacity was assessed by incubating DCs with dextran-FITC during 1, 2, and 4 h. Results are expressed as the difference between MFI of cells incubated at 37 and 4°C with the antigen and are represented as the mean ± SEM of four independent experiments. Significant differences are expressed in relation to iDCs condition. (D) For evaluating antigen-presentation ability, DCs generated from HLA-DRB1*0101 donors were pulsed with the human type II collagen peptide (hCII259–273) and co-cultured with the HLA-DR1-restricted T cell hybridoma (hCII-9.1). Unpulsed DCs and DCs loaded with an irrelevant chicken peptide (iPept) were used as controls. Graphs show the proliferative responses of CTLL-2 cells incubated with supernatants obtained from those co-cultures and assessed by flow cytometry. Data are represented as the mean ± SEM of three independent experiments. For (C,D), statistical differences were calculated using two-way ANOVA followed by Bonferroni post-test (*P < 0.05; **P < 0.01; ***P < 0.001).
Figure 2
Figure 2
MPLA-tDCs modulate memory CD4+ T cells responses in an antigen-specific way. For the assessment of their T cell-stimulatory capacity, PPD-pulsed DCs were co-cultured with autologous CFSE-labeled memory CD4+ T cells. Un-loaded DCs were used as control. Data were normalized by subtracting values of unpulsed conditions to antigen-specific conditions. (A) Representative dot plots of IFN-γ (top) and IL-17 (bottom) expression from 10 independent experiments are shown. (B) Proliferation of CD4+ T cells was determined by CFSE dilution through flow cytometry, and graphic representation of normalized data of the percentage of CFSElow in CD4+ T cells is shown. (C) IFN-γ and (D) IL-17 expression was detected intracellularly and analyzed by flow cytometry. Graphic representation of normalized data of the percentage of IFN-γ and IL-17 producing proliferating CD4+ T cells (CFSElow) is shown. In (B–D), statistical differences were calculated using Friedman test followed by Duns post-test (*P < 0.05; ***P < 0.001). (E) Representative dot plots of cell viability measured after 6 days of co-culture and expressed as the percentage of annexin-V and 7-AAD-negative cells are shown.
Figure 3
Figure 3
MPLA-tDCs render memory CD4+ T cells to be hyporesponsive to restimulation. For restimulation assays, memory CD4+ T cells were primed with PPD-loaded DC subsets and then were recovered, washed, labeled with CFSE, and restimulated with unpulsed or PPD-pulsed mDCs. Data were normalized by subtracting values of unpulsed conditions to antigen-specific conditions. (A) Representative dot plots of IFN-γ expression from six independent experiments are shown. (B) Proliferation of restimulated primed-CD4+ T cells was determined by CFSE dilution through flow cytometry and graphic representation of normalized data of the percentage of CFSElow in CD4+ T cells is shown. (C) IFN-γ expression was detected intracellularly and analyzed by flow cytometry. Graphic representation of normalized data of the percentage of IFN-γ producing proliferating CD4+ T cells (CFSElow) is shown. (D) IL-10 secretion levels from mDC/primed-T cell co-culture supernatants were measured using ELISA. For (B–D), statistical differences were calculated using Friedman test (for non-parametric data) or one-way ANOVA (for normally distributed data) followed by Duns or Tukey post-test, respectively (*P < 0.05; **P < 0.01; ***P < 0.001).
Figure 4
Figure 4
Naive CD4+ T cells primed by MPLA-tDCs do not exhibit a regulatory phenotype and become hyporesponsive to restimulation. MPLA-tDCs ability to induce phenotypic regulatory properties on naive CD4+ T cells after co-culturing was evaluated. (A) Expression of IL-10, FOXP3 in combination to CD25, CTLA-4, and CD39 was evaluated by flow cytometry. Graphic analyses of MFI measurements are expressed as box-and-whiskers plot from minimum to maximum values (n = 5). Statistical differences were calculated using Friedman test (for non-parametric data) or one-way ANOVA (for normally distributed data) followed by Duns or Tukey post-test, respectively (*P < 0.05; **P < 0.01; ***P < 0.001). (B) Representative dot plots of cell viability measured after 6 days of co-culture and expressed as the percentage of annexin-V and 7-AAD-negative cells are shown. For restimulation assays, naive CD4+ T cells were primed with PPD-loaded DC subsets and then were recovered, washed, labeled with CFSE, and restimulated with unpulsed or PPD-pulsed mDCs. Data were normalized by subtracting values of unpulsed conditions to antigen-specific conditions. (C) Representative dot plots of IFN-γ expression from six independent experiments are shown. (D) Proliferation of restimulated primed-CD4+ T cells was determined by CFSE dilution through flow cytometry, and graphic representation of normalized data of the percentage of CFSElow in CD4+ T cells is shown. (E) IFN-γ expression was detected intracellularly and analyzed by flow cytometry. Graphic representation of normalized data of the percentage of IFN-γ producing proliferating CD4+ T cells (CFSElow) is shown. (F) IL-10 secretion levels from mDC/primed-T cell co-culture supernatants were measured using ELISA. For (D–F), statistical differences were calculated using one-way ANOVA followed by Tukey post-test (*P < 0.05; **P < 0.01; ***P < 0.001).
Figure 5
Figure 5
MPLA-tDCs endow naive CD4+ T cells with the ability to suppress Th1 and Th17 responses. To evaluate the ability of MPLA-tDCs to induce functional regulatory properties on naive CD4+ T cells, these cells were primed with PPD-loaded DC subsets and then were recovered, washed, and added to a co-culture of CFSE-labeled responder CD4+ T cells and PPD-pulsed mDCs. Responder CD4+ T cells co-cultured with mDCs and without the addition of primed-naive CD4+ T cells were used as control. (A) Gate strategy is shown: R1 = lymphocytes region, R2 = CFSE + population. (B) Representative dot plots of IFN-γ (top) and IL-17 (bottom) expression from seven independent experiments are shown. (C) Proliferation of responder CD4+ T cells in presence of primed-naive CD4+ T cells was determined by CFSE dilution through flow cytometry, and graphic representation of the percentage of CFSElow in CD4+ T cells is shown. (D) IFN-γ and (E) IL-17 expression were detected intracellularly and analyzed by flow cytometry. Graphic representation of the percentage of IFN-γ and IL-17 producing proliferating CD4+ T cells (CFSElow) is shown. For (C–E), statistical differences were calculated using one-way ANOVA followed by Tukey post-test (*P < 0.05; **P < 0.01).

Similar articles

Cited by

References

    1. Glück T, Kiefmann B, Grohmann M, Falk W, Straub RH, Schölmerich J. Immune status and risk for infection in patients receiving chronic immunosuppressive therapy. J Rheumatol (2005) 32(8):1473–80. - PubMed
    1. Gutierrez-Dalmau A, Campistol JM. Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review. Drugs (2007) 67(8):1167–98.10.2165/00003495-200767080-00006 - DOI - PubMed
    1. van Duivenvoorde L, van Mierlo G, Boonman Z, Toes R. Dendritic cells: vehicles for tolerance induction and prevention of autoimmune diseases. Immunobiology (2006) 211(6–8):627–32.10.1016/j.imbio.2006.05.014 - DOI - PubMed
    1. Banchereau J, Steinman R. Dendritic cells and the control of immunity. Nature (1998) 392(6673):245–52.10.1038/32588 - DOI - PubMed
    1. Moser M. Dendritic cells in immunity and tolerance – do they display opposite functions? Immunity (2003) 19(1):5–8.10.1016/S1074-7613(03)00182-1 - DOI - PubMed